Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, August 02, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Huber Cooling Circulators Now Reduced in Price
Monday, January 06, 2014
Huber has reduced the prices of its bath circulators CC®-510(w), CC®-515(w), CC®-520w und CC®-525w.

Powerful Evaporator for Drug Discovery
Thursday, January 02, 2014
The HT-4X centrifugal evaporator from Genevac provides optimised sample preparation capabilities for scientists working in the drug discovery environment.

Overhead Stirrer Provides an Effective Tool for Rapid Screening
Thursday, January 02, 2014
An independent report demonstrates how the Asynt Vortex overhead stirrer system provides an effective tool for rapid screening of a range of reaction conditions in parallel - an essential for efficient process development.

Syrris’ Customers Receive an Exciting Invite
Friday, December 20, 2013
Exclusive Customer Club launched by Syrris.

StarFish™ the Multi-Experiment Workstation from Radleys
Monday, December 16, 2013
Small footprint, big work load.

A Safety Guide for Using Laboratory Heating Blocks
Monday, December 09, 2013
IN BEST PRACTICE GUIDE from Asynt.

New DuPont™ Tychem® 4000 S Disposable Coverall
Thursday, December 05, 2013
Supple and lightweight garment offers a barrier to broad range of chemicals.

New Checkweighing Solution from Mettler-Toledo Garvens
Wednesday, December 04, 2013
New multiple-lane checkweigher boosts productivity and product quality.

Radleys Findenser is Reviewed by American Chemical Society
Tuesday, December 03, 2013
Findenser featured in ACS Sustainable Chemistry & Engineering Journal.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 903
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv